Biological E's vaccine Corbevax receives emergency use nod for children | Latest News India - Hindustan Times
close_game
close_game

Biological E's Covid vaccine Corbevax receives emergency use nod for children aged 12-18 yrs

By | Written by Shubhangi Gupta, New Delhi
Feb 21, 2022 06:28 PM IST

India's third homegrown Covid-19 vaccine, Corbevax will be administered in two doses, according to reports.

The Drugs Controller General of India (DCGI) on Monday gave an emergency use nod to Hyderabad-based pharmaceutical company Biological E's Coronavirus vaccine ‘Corbevax’ for children aged 12-18 years. 

Corbevax is the third made-in-India vaccine against coronavirus, the other two indigenous vaccines are Covaxin and ZyCoV-D.(MINT_PRINT)
Corbevax is the third made-in-India vaccine against coronavirus, the other two indigenous vaccines are Covaxin and ZyCoV-D.(MINT_PRINT)

India's third homegrown Covid-19 vaccine, Corbevax will be administered in two doses, according to reports. This is the third vaccine approved for use in children aged 12 and above in India, joining Zydus Cadila's DNA shot ZyCoV-D and Bharat Biotech's Covaxin.

Now catch your favourite game on Crickit. Anytime Anywhere. Find out how

Also read | Biological E gets nod to conduct trials of its Corbevax as booster dose

Prior to this, the Corbevax vaccine had received an Emergency Use Authorization (EUA) from the DCGI's Subject Expert Committee (SEC) for the 12 to 18 age group, subject to certain conditions, according to news agency ANI.

The EUA was recommended after reviewing the safety and immunogenicity data of the clinical study of Corbevax in children and adolescents.

The expected cost of the vaccine is 145 excluding taxes, ANI had quoted official sources as saying.

Speaking on the Corbevax shots, National Technical Advisory Group on Immunisation (NTAGI) chief Dr N K Arora had said that the vaccine was safe and offered good immunogenicity and higher antibody levels as compared to some other vector vaccines.

India has, so far, vaccinated more than 76 million children aged 15-17 against the Coronavirus disease, mainly using Covaxin.

Get World Cup ready with Crickit! From live scores to match stats, catch all the action here. Explore now!

See more

Get Current Updates on India News, Budget 2024, Weather Today along with Latest News and Top Headlines from India and around the world.

SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Sunday, June 23, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On